Trulieve Looks To Raise Funds In The United States Following Filing Of S-1

Trulieve Cannabis (CSE: TRUL) last night announced that it is conducting a marketed public offering of subordinate voting shares in both Canada and the United States. While a price tag was not placed on the financing, what is known is that the firm is looking to sell 4.4 million shares of its equity.

The offering, despite having few details, is significant for the company in that it marks the first such offering being conducted within the United States. The firm is able to do so following the filing of a Form S-1 with the SEC, also known as a registration statement, which follows the footsteps of industry peer Green Thumb Industries, whom took similar steps earlier this year.

The financing, while not yet priced, is to be lead by Canaccord Genuity, with a total of 4.4 million subordinate voting shares to be sold with no warrant attached. An over-allotment option has also been granted for a further 660,066 shares as well, to bring the total financing to roughly 5.1 million shares. No timeline has been provided for the closing of the offering.

Proceeds from the offering are to be used to fund business development and for general working capital.

Trulieve Cannabis last traded at $56.35 on the CSE.


Information for this briefing was found via Sedar and Trulieve Cannabis Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Trulieve: Canaccord Retains $97 Price Target Following Harvest Health Transaction

On October 1, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition...

Sunday, October 10, 2021, 01:03:00 PM

Trulieve Sees Flat Q2 Results, Lowers Guidance For Full Fiscal Year

Growth appears to be slowing for Trulieve Cannabis (CSE: TRUL), whom this morning reported its...

Wednesday, August 10, 2022, 08:21:12 AM

Trulieve Reports Q1 Revenues of $96.1 Million, Net Income of $14.0 Million

Trulieve Cannabis (CSE: TRUL) reported its first quarter 2020 financial results this morning, posting revenues...

Wednesday, May 20, 2020, 08:28:56 AM

Canaccord Raises Trulieve Price Target To $75 From $60

The last two weeks have been quite an enjoyable time for U.S cannabis sector investors....

Wednesday, January 13, 2021, 02:53:00 PM

Trulieve Closes $287.5 Million Financing With US-Based Investors

Trulieve Cannabis (CSE: TRUL) has closed its previously announced marketed public offering of shares, the...

Monday, April 12, 2021, 09:55:40 AM